Evidence map›Paper›PMID 41225025›Full record

ArticleAnnals of hematology2025

Correction to: Continous or fixed carfilzomib, lenalidomide and dexamethasone (KRD) for relapsed-refractory multiple myeloma: long-term follow-up from a multicenter, retrospective real-life survey from European myeloma network (EMN) Italy : Correction to: annals of hematology.

Concetta Conticello, Vittorio Del Fabro, Alessandra Romano, Anna Mele, Roberto Mina, Sara Bringhen, Alessandra Orofino, Elisabetta Antonioli, Stefano Pulini, Lorenzo De Paoli and 34 more

Abstract readPublished Erratum
In one paragraph

Article in Annals of hematology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

44 authors.

Concetta ConticelloA.O.U. Policlinico "G. Rodolico-San Marco", Catania, Italy. ettaconticello@gmail.com.
Vittorio Del FabroFaculty of Medicine and Surgery, "Kore" University of Enna, Enna, Italy.
Alessandra RomanoA.O.U. Policlinico "G. Rodolico-San Marco", Catania, Italy.
Anna MeleUO Ematologia e Centro Trapianto, Azienda Ospedaliera Cardinale Panico, Tricase, Italy.
Roberto MinaDivision of Hematology 1, Department of MolecularBiotechnology and Health Sciences, AOU Città della Salute e della Scienza di Torino, University of Turin, Torino, Torino, Italy.
Sara BringhenSSD Clinical trials in onco-ematologia e mieloma multiplo, Dipartimento di Oncologia, AOU Città della Salute e della Scienza di Torino, Torino, Italy.
Alessandra OrofinoDipartimento di Specialità Medico-Chirurgiche, CHIRMED, Sezione di Ematologia, Università degli Studi di Catania, Catania, Italy.
Elisabetta AntonioliSODc Ematologia, Azienda Ospedaliero-Universitaria Careggi, Firenze, Italy.
Stefano PuliniDepartment of Oncology and Hematology, Santo Spirito Hospital, Clinical Hematology Unit, Pescara, Italy.
Lorenzo De PaoliSS Ematologia SC Medicina ASL Vercelli, Vercelli, Italy.
Tommaso ZaSezione di Ematologia, Fondazione Policlinico Gemelli IRCCS, Università Cattolica, Roma, Italy.
Emilia CotziaUOC, Ematologia Asp 8 Siracusa, Siracusa, Italy.
Federica EliaA.O.U. Policlinico "G. Rodolico-San Marco", Catania, Italy.
Andrea CassonDivision of Hematology 1, Department of MolecularBiotechnology and Health Sciences, AOU Città della Salute e della Scienza di Torino, University of Turin, Torino, Torino, Italy.
Eleonora PreteUO Ematologia e Centro Trapianto, Azienda Ospedaliera Cardinale Panico, Tricase, Italy.
Stefania CitisoUO Ematologia e Centro Trapianto, Azienda Ospedaliera Cardinale Panico, Tricase, Italy.
Carmine LiberatoreDepartment of Medicine and Aging Sciences, G. D'Annunzio University, Chieti, Italy.
Gloria Margiotta-CasaluciDivision of Hematology, Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy.
Francesca FazioHematology, Department of Translational and Precision Medicine-Azienda, Policlinico Umberto I-Sapienza Univercity, Roma, Italy.
Sonia MorèClinica di Ematologia, Azienda Ospedaliero Universitaria delle Marche, Ancona, Italy.
Irene AttucciSODc Ematologia, Azienda Ospedaliero-Universitaria Careggi, Firenze, Italy.
Fabrizio AccardiEmatologia Ospedale Cervello, Palermo, Italy.
Velia BongarzoniAzienda Ospedaliera San Giovanni/Addolorata, Roma, Italy.
Silvia MangiacavalliDivision of Hematology, I.R.C.C.S. Policlinico San Matteo, University of Pavia, Pavia, Italy.
Elena RossiSezione di Ematologia, Fondazione Policlinico Gemelli IRCCS, Università Cattolica, Roma, Italy.
Donato ManninaDipartimento di Oncoematologia, Ospedale Papardo, Messina, Italy.
Bruno GaribaldiA.O.U. Policlinico "G. Rodolico-San Marco", Catania, Italy.
Rita RizziDipartimento di Medicina di Precisione e Rigenerativa e Area Ionica (dIMEPREJ), Scuola di Medicina, Bari-SC di Ematologia con Trapianto, AOU Consorziale Policlinico, Università degli Studi "Aldo Moro", Bari, Italy.
Monica Di CeccaUniversity Campus Biomedico di Roma, Roma, Italy.
Bernardino RossiniHematology and Cell Therapy UniversityIRCCS Istituto Tumori Giovanni Paolo II, Bari, Italy.
Giuseppina UccelloDivisione Clinicizzata di Ematologia ARNAS Garibaldi Nesima, Catania, Italy.
Cirino BottaDepartment of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo, Palermo, Italy.
Dario LeottaDipartimento di Specialità Medico-Chirurgiche, CHIRMED, Sezione di Ematologia, Università degli Studi di Catania, Catania, Italy.
Donatella VincelliGrande Ospedale Metropolitano Bianchi MelacrinoMorelli, Reggio Calabria, Italy.
Massimo GentileDepartment of Onco- Hematology, AO of Cosenza, Hematology Unit, Cosenza, Italy.
Alfonso PiciocchiGIMEMA Foundation, Roma, Italy.
Giovanni MarsiliGIMEMA Foundation, Roma, Italy.
Francesca PatriarcaEmatologia, ASUFC, DMED, University of Udine, Italy.
Renato ZambelloDipartimento di Medicina (DIMED), Ematologia e Immunologia Clinic, Università di Padova, Padova, Italy.
Pellegrino MustoDipartimento di Medicina di Precisione e Rigenerativa e Area Ionica (dIMEPREJ), Scuola di Medicina, Bari-SC di Ematologia con Trapianto, AOU Consorziale Policlinico, Università degli Studi "Aldo Moro", Bari, Italy.
Mario BoccadoroDepartment of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy.
Massimo OffidaniClinica di Ematologia, Azienda Ospedaliero Universitaria delle Marche, Ancona, Italy.
Maria Teresa PetrucciHematology, Department of Translational and Precision Medicine-Azienda, Policlinico Umberto I-Sapienza Univercity, Roma, Italy.
Francesco Di RaimondoA.O.U. Policlinico "G. Rodolico-San Marco", Catania, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41225025
PMCPMC12764578

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.